Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001641172-25-026397

Options or other derivatives

  • SVP, Clinical Development acquired 272,652 shares (grant or award)
  • SVP, Clinical Development returned 272,652 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · SVP, Clinical Development

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-09-01 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −207,652 0 D
2025-09-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +207,652 207,652 D
2025-09-01 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −65,000 0 D
2025-09-01 Grant or award : show line 4 in the form Stock Option (Right to Buy) +65,000 65,000 D
Loading xslF345X05/ownership.xml…